HK1060971A1 - Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt - Google Patents
Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt Download PDFInfo
- Publication number
- HK1060971A1 HK1060971A1 HK04103826A HK04103826A HK1060971A1 HK 1060971 A1 HK1060971 A1 HK 1060971A1 HK 04103826 A HK04103826 A HK 04103826A HK 04103826 A HK04103826 A HK 04103826A HK 1060971 A1 HK1060971 A1 HK 1060971A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- dosage form
- administered parenterally
- parenterally according
- ethylene oxide
- regulators
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE20001059020 | 2000-11-28 | ||
DE10059020A DE10059020A1 (de) | 2000-11-28 | 2000-11-28 | Parenteral applizierbare Darreichungsformen |
PCT/EP2001/013789 WO2002043723A1 (de) | 2000-11-28 | 2001-11-27 | Parental applizierbare darreichungsformen enthaltend eine suspension des salzes aus tramadol und diclofenac |
Publications (2)
Publication Number | Publication Date |
---|---|
HK1060971A1 true HK1060971A1 (en) | 2004-09-03 |
HK1060971B HK1060971B (en) | 2006-12-22 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
DE10059020A1 (de) | 2002-05-29 |
CN1477955A (zh) | 2004-02-25 |
EP1368016A1 (de) | 2003-12-10 |
CN100384410C (zh) | 2008-04-30 |
US20030203037A1 (en) | 2003-10-30 |
DE50109572D1 (de) | 2006-05-24 |
EP1368016B1 (de) | 2006-04-19 |
CY1105625T1 (el) | 2010-12-22 |
PT1368016E (pt) | 2006-08-31 |
JP4188084B2 (ja) | 2008-11-26 |
AU2002224896A1 (en) | 2002-06-11 |
ES2262703T3 (es) | 2006-12-01 |
JP2004514692A (ja) | 2004-05-20 |
DK1368016T3 (da) | 2006-07-31 |
US6875447B2 (en) | 2005-04-05 |
WO2002043723A1 (de) | 2002-06-06 |
ATE323477T1 (de) | 2006-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100722502B1 (ko) | 사이프로플록사신 및 덱사메타손 함유 국소용 현탁제 | |
JP5887368B2 (ja) | 共溶媒処方物 | |
US6147122A (en) | Propofol composition containing sulfite | |
TWI495469B (zh) | 含有氟喹諾酮抗生素藥物之經改良藥學組成物 | |
US12168011B2 (en) | Formulation production process | |
KR20210141448A (ko) | 안구 표면 질환을 치료하기 위한 안과용 약학 조성물 및 방법 | |
KR20130050394A (ko) | 수의학 약물에서 멜록시캄 제형의 용도 | |
US6875447B2 (en) | Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt | |
RU2286774C2 (ru) | Препарат эсмолола | |
KR102100271B1 (ko) | 조절된 방출 조성물 및 이들의 사용 방법 | |
HK1060971B (en) | Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt | |
EP1119373A1 (en) | Oxybutynin formulations and methods of use | |
CN111565761A (zh) | 荧光素和丁氧普鲁卡因组合物 | |
US7838034B2 (en) | Intravenous pharmaceutical form of administration | |
WO2010082092A1 (en) | Propofol based anesthetic with preservative | |
KR20190138858A (ko) | 목시플록사신이 담긴 사전 충전형 시린지 | |
AU2015261543B2 (en) | Controlled release compositions and their methods of use | |
EP2934524B1 (en) | Penethamate veterinary injectable formulations | |
NZ607636A (en) | Controlled release compositions and their methods of use | |
WO2000067753A1 (en) | Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20131127 |